Surgical treatment of gastrointestinal tumors in a COVID‐19 pandemic hospital: Can open versus minimally invasive surgery be safely performed?. Issue 8 (19th August 2021)

• Record Type: Journal Article
• Authors: Özdemir, Yılmaz; Temiz, Ayetullah
• Is Part Of: Journal of surgical oncology. Volume 124:Issue 8(2021)
• Page Start: 1217
• Page End: 1223
• Publication Date: 2021-08-19
• Subjects: COVID‐19 -- gastrointestinal cancer -- pandemic; Cancer -- Surgery -- Periodicals; Neoplasms -- Periodicals; 616
• DOI: 10.1002/jso.26653
• Languages: English
• ISSNs: 0022-4790

Abstract

Abstract: Purpose: In order for patients with gastrointestinal cancer not to suffer the consequences of delayed treatment, they should be operated on in pandemic hospitals under adequate conditions. We aimed to discuss the outcomes of our gastrointestinal cancer surgery patients and to present our patient management recommendations to resume operative treatment during the ongoing COVID‐19 pandemic while taking into account hospital facilities. Materials and Methods: This study included 129 gastrointestinal cancer patients who underwent surgery between March 2020 and May 2021 in the gastrointestinal surgery clinic of our hospital, which was assigned as a pandemic hospital in March 2020. Patients' demographic characteristics and preoperative and postoperative findings were recorded. Results: Among the patients, 42.6% ( n = 55) were female and 57.3% ( n = 74) were male. The mean age was 61.89 ± 3.4 years. The primary tumor organs were the stomach 37.2% ( n = 48), pancreas 36.4% ( n = 47), rectum 11.6% ( n = 15), colon 8.5% ( n = 11), and esophagus 6.2% ( n = 8). The patients were treated with open (75.2%, n = 97) or minimally invasive surgery (24.8%, n = 32; laparoscopic 11.6%, n = 15; robotic 13.2%, n = 17). Eight patients tested positive for COVID‐19 before surgery. No patients developed COVID‐19 during postoperative intensive care or after being moved to the floor unit. There was no COVID‐19‐related morbidity or mortality. Conclusion: Failure to treat gastrointestinal cancer patients during the pandemic may result in undesirable consequences, such as stage shift and mortality. Cancer patients can be treated safely with conventional and minimally invasive surgery guided by current recommendations and experience.